Metastatic uveal melanoma has been a difficult condition to treat due to a lack of effective treatment options. Authors of a recent review aimed to determine the benefit of immune checkpoint inhibition...
In a multicenter, randomized, open-label, phase 3 trial, researchers set out to determine whether an advanced surgical therapy, isolated hepatic perfusion, could improve outcomes among previously untreated...
A group of researchers aimed to determine the incidence rate of brain metastases in patients with metastatic uveal melanoma using data from comprehensive cancer centers.
Researchers determined the impact of melanoma subtypes on cutaneous immune-related adverse events and survival among those who received immune checkpoint inhibitor therapy.
In her session, Sancy Leachman, MD, discussed everything a primary care provider needs to know about skin cancer, how to detect it early, and when to refer to dermatology.
